Brian Stolz
2019
In 2019, Brian Stolz earned a total compensation of $8.1M as Chief Operating Officer at BridgeBio Pharma.
Compensation breakdown
| Bonus | $93,750 |
|---|---|
| Option Awards | $1,045,003 |
| Salary | $146,780 |
| Stock Awards | $6,860,780 |
| Total | $8,146,313 |
Stolz received $6.9M in stock awards, accounting for 84% of the total pay in 2019.
Stolz also received $93.8K in bonus, $1M in option awards and $146.8K in salary.
Rankings
In 2019, Brian Stolz's compensation ranked 1,062nd out of 13,971 executives tracked by ExecPay. In other words, Stolz earned more than 92.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,062 out of 13,971 | 92nd |
Division Manufacturing | 363 out of 5,692 | 94th |
Major group Chemicals And Allied Products | 108 out of 2,189 | 95th |
Industry group Drugs | 84 out of 1,875 | 96th |
Industry Pharmaceutical Preparations | 66 out of 1,387 | 95th |
Source: SEC filing on April 22, 2020.
Stolz's colleagues
We found two more compensation records of executives who worked with Brian Stolz at BridgeBio Pharma in 2019.